Don Hankey

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Don Hankey

Don Hankey was last confirmed as Chairman at Bone Biologics Corp (BBLG) in a filing dated August 8, 2024. Bone Biologics Corp reported in an 8-K filed October 4, 2024 that Don Hankey resigned as director, effective October 1, 2024.

“On October 1, 2024, Don Hankey informed Bone Biologics Corporation (the "Company") of his resignation as a director of the Company effective immediately.”

Bone Biologics Corp Form 8-K, filed October 4, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Don Hankey's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Bone Biologics Corp (BBLG)
Chairman

Proxy statement

Start not stated–2024-08-08

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Bone Biologics Corp

BBLG

Chairman

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: director Bone Biologics Corp (BBLG)
2024-10-01